Show simple item record

dc.contributor.authorCoulson, Fionaen_US
dc.contributor.authorD. Fryer, Allisonen_US
dc.date.accessioned2017-05-03T14:15:11Z
dc.date.available2017-05-03T14:15:11Z
dc.date.issued2003en_US
dc.identifier.issn01637258en_US
dc.identifier.doi10.1016/S0163-7258(03)00004-4en_US
dc.identifier.urihttp://hdl.handle.net/10072/6131
dc.description.abstractParasympathetic nerves provide the dominant autonomic innervation of the airways. Release of acetylcholine from parasympathetic nerves activates postjunctional muscarinic receptors present on airway smooth muscle, submucosal glands, and blood vessels to cause bronchoconstriction, mucus secretion, and vasodilatation, respectively. Acetylcholine also feeds back onto prejunctional muscarinic receptors to enhance or inhibit further acetylcholine release. In asthma and chronic obstructive pulmonary disease, bronchoconstriction and mucus secretion is increased and the airways are hyperresponsive to contractile agents. These changes are due to increased parasympathetic nerve activity. The number and function of postjunctional muscarinic receptors in the airways are unchanged in animal models of asthma. Rather, it is the supply of acetylcholine to the postjunctional cells (smooth muscle and submucosal gland) that is increased. The increase in acetylcholine release occurs because prejunctional, inhibitory M2 muscarinic receptors on the parasympathetic nerves are dysfunctional. M2 muscarinic receptor dysfunction and subsequent airway hyperreactivity have been demonstrated to occur in animals in response to a variety of triggers, including antigen challenge, virus infection, ozone exposure, and vitamin A deficiency. In humans, there is evidence that loss of M2 muscarinic receptor function is related to asthma. The mechanisms by which neuronal M2 muscarinic receptor function is lost and its relevance to human airway disease are discussed in this review.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_US
dc.languageEnglishen_US
dc.language.isoen_US
dc.publisherPergamon-Elsevier Science Ltd.en_US
dc.publisher.placeUKen_US
dc.relation.ispartofpagefrom59en_US
dc.relation.ispartofpageto69en_US
dc.relation.ispartofjournalPharmacology and Therapeuticsen_US
dc.relation.ispartofvolume98en_US
dc.subject.fieldofresearchcode321027en_US
dc.titleMuscarinic acetylcholine receptors and airway diseasesen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.facultyGriffith Health, School of Medical Scienceen_US
gro.date.issued2015-05-06T21:36:41Z
gro.hasfulltextNo Full Text
gro.griffith.authorCoulson, Fiona


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record